|
Insider Trading: VIROPHARMA INC
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of VIROPHARMA INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of VIROPHARMA INC since year 2005. Table 2 shows the detailed insider transactions of VIROPHARMA INC since 2005.
The reporting company's ticker symbol is VPHM.
The reporting company's CIK number is 946840.
The total value of stock buying since 2005 is $25,126,170.
The total value of stock sales is $59,437,082.
The total value of stock exercises is $512,617.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at VIROPHARMA INC (VPHM) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at VIROPHARMA INC (VPHM) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for VIROPHARMA INC (VPHM).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-03 | 167,278 | 1,445,071 | 0 | 0 | 0 | 0 |
| 2008-02 | 0 | 0 | 0 | 0 | 36,900 | 99,999 |
| 2008-01 | 502,883 | 4,442,704 | 0 | 0 | 0 | 0 |
| 2007-11 | 2,392,787 | 17,783,875 | 0 | 0 | 0 | 0 |
| 2007-09 | 0 | 0 | 0 | 0 | 39,477 | 94,744 |
| 2007-08 | 41,120 | 334,971 | 0 | 0 | 0 | 0 |
| 2007-04 | 0 | 0 | 1,529,314 | 23,494,253 | 0 | 0 |
| 2007-02 | 0 | 0 | 10,000 | 180,189 | 10,000 | 151,250 |
| 2007-01 | 0 | 0 | 5,000 | 82,500 | 5,000 | 75,624 |
| 2006-12 | 0 | 0 | 7,000 | 104,982 | 7,000 | 91,000 |
| 2006-09 | 6,000 | 73,599 | 0 | 0 | 0 | 0 |
| 2006-05 | 20,100 | 195,683 | 0 | 0 | 0 | 0 |
| 2006-02 | 0 | 0 | 1,678,430 | 35,575,158 | 0 | 0 |
| 2005-06 | 24,000 | 135,875 | 0 | 0 | 0 | 0 |
| 2005-05 | 232,834 | 714,392 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for VIROPHARMA INC (VPHM)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-03-17 | Baker Felix (10% Owner) | Purchase | 7,834 | 8.14 | 63,735 |
| 2008-03-14 | Baker Felix (10% Owner) | Purchase | 5,000 | 8.67 | 43,325 |
| 2008-03-13 | Baker Felix (10% Owner) | Purchase | 70,884 | 8.69 | 616,157 |
| 2008-02-13 | De Rosen Michel (Chief Executive Officer) | Option Exercise | 36,900 | 2.71 | 99,999 |
| 2008-01-09 | Baker Felix (10% Owner) | Purchase | 102,178 | 8.95 | 914,317 |
| 2008-01-08 | Baker Felix (10% Owner) | Purchase | 149,500 | 8.76 | 1,309,124 |
| 2007-11-09 | Baker Felix (10% Owner) | Purchase | 285,000 | 7.63 | 2,174,776 |
| 2007-11-08 | Baker Felix (10% Owner) | Purchase | 500,000 | 7.43 | 3,716,997 |
| 2007-11-07 | Soland Daniel B (VP, Chief Commercial Officer) | Purchase | 10,000 | 7.26 | 72,600 |
| 2007-11-07 | Baker Felix (10% Owner) | Purchase | 400,000 | 7.27 | 2,909,757 |
| 2007-11-01 | Soland Daniel B (VP, Chief Commercial Officer) | Purchase | 15,000 | 8.31 | 124,650 |
| 2007-09-04 | De Rosen Michel (Chief Executive Officer) | Option Exercise | 39,477 | 2.40 | 94,744 |
| 2007-08-16 | Soland Daniel B (VP, Chief Commercial Officer) | Purchase | 15,000 | 8.00 | 120,000 |
| 2007-08-16 | Milano Vincent (VP, COO & CFO) | Purchase | 4,000 | 8.15 | 32,614 |
| 2007-08-16 | De Rosen Michel (Chief Executive Officer) | Purchase | 12,120 | 8.17 | 99,020 |
| 2007-08-15 | Claypool William D Md (Director) | Purchase | 10,000 | 8.33 | 83,337 |
| 2007-04-17 | Baker Felix (10% Owner) | Sale | 181,569 | 15.44 | 2,803,471 |
| 2007-04-16 | Baker Felix (10% Owner) | Sale | 87,000 | 15.49 | 1,347,706 |
| 2007-04-13 | Baker Felix (10% Owner) | Sale | 503,485 | 15.31 | 7,709,586 |
| 2007-02-07 | Glaser Robert (Director) | Sale | 10,000 | 18.02 | 180,189 |
| 2007-02-07 | Glaser Robert (Director) | Option Exercise | 10,000 | 15.12 | 151,250 |
| 2007-01-30 | Glaser Robert (Director) | Sale | 2,500 | 17.00 | 42,500 |
| 2007-01-30 | Glaser Robert (Director) | Option Exercise | 2,500 | 15.12 | 37,812 |
| 2007-01-25 | Glaser Robert (Director) | Sale | 2,500 | 16.00 | 40,000 |
| 2007-01-25 | Glaser Robert (Director) | Option Exercise | 2,500 | 15.12 | 37,812 |
| 2006-12-06 | Doyle Thomas F (VP, General Counsel) | Sale | 7,000 | 15.00 | 104,982 |
| 2006-12-06 | Doyle Thomas F (VP, General Counsel) | Option Exercise | 7,000 | 13.00 | 91,000 |
| 2006-09-08 | Leone John R (Director) | Purchase | 4,000 | 12.27 | 49,066 |
| 2006-05-09 | De Rosen Michel (Chief Executive Officer) | Purchase | 10,100 | 9.84 | 99,333 |
| 2006-05-08 | Claypool William D Md (Director) | Purchase | 10,000 | 9.64 | 96,350 |
| 2006-02-28 | Baker Felix (10% Owner) | Sale | 423,621 | 20.70 | 8,770,717 |
| 2006-02-27 | Baker Felix (10% Owner) | Sale | 427,517 | 21.68 | 9,269,576 |
| 2005-06-13 | Tarnoff Joshua M (VP, Commerical Opera) | Purchase | 1,500 | 6.60 | 9,900 |
| 2005-06-10 | Claypool William D Md (Director) | Purchase | 10,000 | 5.75 | 57,500 |
| 2005-06-06 | Glaser Robert (Director) | Purchase | 12,500 | 5.48 | 68,475 |
| 2005-05-26 | Claypool William D Md (Director) | Purchase | 10,000 | 4.10 | 41,000 |
| 2005-05-26 | Doyle Thomas F (VP, General Counsel) | Purchase | 5,000 | 3.84 | 19,175 |
| 2005-05-19 | Glaser Robert (Director) | Purchase | 7,500 | 3.76 | 28,200 |
| 2005-05-12 | De Rosen Michel (Chief Executive Officer) | Purchase | 28,500 | 3.51 | 99,949 |
| 2005-05-11 | Brooke Paul A (Director) | Purchase | 126,500 | 3.12 | 394,806 |
| 2005-05-10 | Baker Felix (Director) | Purchase | 11,031 | 2.22 | 24,495 |
| 2005-05-06 | Brooke Paul A (Director) | Purchase | 33,500 | 2.47 | 82,778 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of VIROPHARMA INC (symbol VPHM,
CIK number 946840) see
the Securities and Exchange Commission (SEC) website.
|
|
